Cargando…

Why we need a small data paradigm

BACKGROUND: There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various ‘big data’ efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigoro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hekler, Eric B., Klasnja, Predrag, Chevance, Guillaume, Golaszewski, Natalie M., Lewis, Dana, Sim, Ida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636023/
https://www.ncbi.nlm.nih.gov/pubmed/31311528
http://dx.doi.org/10.1186/s12916-019-1366-x
_version_ 1783435989332525056
author Hekler, Eric B.
Klasnja, Predrag
Chevance, Guillaume
Golaszewski, Natalie M.
Lewis, Dana
Sim, Ida
author_facet Hekler, Eric B.
Klasnja, Predrag
Chevance, Guillaume
Golaszewski, Natalie M.
Lewis, Dana
Sim, Ida
author_sort Hekler, Eric B.
collection PubMed
description BACKGROUND: There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various ‘big data’ efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary ‘small data’ paradigm that can function both autonomously from and in collaboration with big data is also needed. By ‘small data’ we build on Estrin’s formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit. MAIN BODY: The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality. CONCLUSION: Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved.
format Online
Article
Text
id pubmed-6636023
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66360232019-07-25 Why we need a small data paradigm Hekler, Eric B. Klasnja, Predrag Chevance, Guillaume Golaszewski, Natalie M. Lewis, Dana Sim, Ida BMC Med Debate BACKGROUND: There is great interest in and excitement about the concept of personalized or precision medicine and, in particular, advancing this vision via various ‘big data’ efforts. While these methods are necessary, they are insufficient to achieve the full personalized medicine promise. A rigorous, complementary ‘small data’ paradigm that can function both autonomously from and in collaboration with big data is also needed. By ‘small data’ we build on Estrin’s formulation and refer to the rigorous use of data by and for a specific N-of-1 unit (i.e., a single person, clinic, hospital, healthcare system, community, city, etc.) to facilitate improved individual-level description, prediction and, ultimately, control for that specific unit. MAIN BODY: The purpose of this piece is to articulate why a small data paradigm is needed and is valuable in itself, and to provide initial directions for future work that can advance study designs and data analytic techniques for a small data approach to precision health. Scientifically, the central value of a small data approach is that it can uniquely manage complex, dynamic, multi-causal, idiosyncratically manifesting phenomena, such as chronic diseases, in comparison to big data. Beyond this, a small data approach better aligns the goals of science and practice, which can result in more rapid agile learning with less data. There is also, feasibly, a unique pathway towards transportable knowledge from a small data approach, which is complementary to a big data approach. Future work should (1) further refine appropriate methods for a small data approach; (2) advance strategies for better integrating a small data approach into real-world practices; and (3) advance ways of actively integrating the strengths and limitations from both small and big data approaches into a unified scientific knowledge base that is linked via a robust science of causality. CONCLUSION: Small data is valuable in its own right. That said, small and big data paradigms can and should be combined via a foundational science of causality. With these approaches combined, the vision of precision health can be achieved. BioMed Central 2019-07-17 /pmc/articles/PMC6636023/ /pubmed/31311528 http://dx.doi.org/10.1186/s12916-019-1366-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Debate
Hekler, Eric B.
Klasnja, Predrag
Chevance, Guillaume
Golaszewski, Natalie M.
Lewis, Dana
Sim, Ida
Why we need a small data paradigm
title Why we need a small data paradigm
title_full Why we need a small data paradigm
title_fullStr Why we need a small data paradigm
title_full_unstemmed Why we need a small data paradigm
title_short Why we need a small data paradigm
title_sort why we need a small data paradigm
topic Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636023/
https://www.ncbi.nlm.nih.gov/pubmed/31311528
http://dx.doi.org/10.1186/s12916-019-1366-x
work_keys_str_mv AT heklerericb whyweneedasmalldataparadigm
AT klasnjapredrag whyweneedasmalldataparadigm
AT chevanceguillaume whyweneedasmalldataparadigm
AT golaszewskinataliem whyweneedasmalldataparadigm
AT lewisdana whyweneedasmalldataparadigm
AT simida whyweneedasmalldataparadigm